Notice2021-19563
Methionine From Japan and Spain
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 10, 2021
Issuing agencies
International Trade Commission
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 173 (Friday, September 10, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 173 (Friday, September 10, 2021)]
[Notices]
[Pages 50743-50744]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-19563]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 731-TA-1535-1536 (Final)]
Methionine From Japan and Spain
Determinations
On the basis of the record \1\ developed in the subject
investigations, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that an industry in the United States is materially injured by
reason of imports of methionine from Japan and Spain, provided for in
subheadings 2930.40.00 and 2930.90.46 of the Harmonized Tariff Schedule
of the United States, that have been found by the U.S. Department of
Commerce (``Commerce'') to be sold in the United States at less than
fair value (``LTFV'').<SUP>2 3</SUP>
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
\2\ 86 FR 38983 and 86 FR 38985 (July 23, 2021).
\3\ The Commission also finds that imports subject to Commerce's
affirmative critical circumstances determination are not likely to
undermine seriously the remedial effect of the antidumping duty
order on Spain.
---------------------------------------------------------------------------
Background
The Commission, pursuant to section 735(b) of the Act (19 U.S.C.
1673d(b)), instituted antidumping duty investigations, effective July
29, 2020, following receipt of petitions filed with the Commission and
Commerce by Novus International Inc., St. Charles, Missouri. Effective,
February 24, 2021, the Commission established a general schedule for
the conduct of the final phase of its investigations on methionine,
following a preliminary determination by Commerce that imports of
methionine from France were being sold at LTFV within the meaning of
section 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the
scheduling of the final phase of the Commission's investigations and of
a public hearing to be held in connection therewith was given by
posting copies of the notice in the Office of the Secretary, U.S.
International Trade Commission, Washington, DC, and by publishing the
notice in the Federal Register of March 9, 2021 (86 FR 13585). In light
of the restrictions on access to the Commission building due to the
COVID-19 pandemic, the Commission conducted its hearing by video
conference on May 11, 2021. All persons who requested the opportunity
were permitted to participate.
The investigation schedules became staggered when Commerce: (i)
[[Page 50744]]
Postponed the final determinations for its antidumping duty
investigations regarding methionine from Japan and Spain; and (ii)
reached an earlier final antidumping duty determination concerning
methionine from France. On June 30, 2021, the Commission issued a final
affirmative determination in its antidumping duty investigation of
methionine from France (86 FR 35826, July 7, 2021). Following
notification of final determinations by Commerce that imports of
methionine from Japan and Spain were being sold at LTFV within the
meaning of section 735(a) of the Act (19 U.S.C. 1673d(a)), notice of
the supplemental scheduling of the final phase of the Commission's
antidumping duty investigations was given by posting copies of the
notice in the Office of the Secretary, U.S. International Trade
Commission, Washington, DC, and by publishing the notice in the Federal
Register of August 2, 2021 (86 FR 41513).
The Commission made these determinations pursuant to Sec. 735(b)
of the Act (19 U.S.C. 1673d(b)). It completed and filed its
determinations in these investigations on September 7, 2021. The views
of the Commission are contained in USITC Publication 5230 (September
2021), entitled Methionine from Japan and Spain: Investigation Nos.
731-TA-1535-1536 (Final).
By order of the Commission.
Issued: September 7, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021-19563 Filed 9-9-21; 8:45 am]
BILLING CODE 7020-02-P
</pre></body>
</html>Indexed from Federal Register on September 10, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.